南京科佰生物科技有限公司官方网站欢迎您的光临!
免费咨询热线: 4008-750-250
科研细胞
药靶细胞
标准品
NGS靶向捕获探针
NCCIT(人畸胎瘤细胞)
CBP61089 | |
I. General information | |
Synonyms: | NCCIT |
Background: | NCCIT was established by Shinichi Teshima (National Cancer Institute, Tokyo, Japan) in 1985 from a mediastinal mixed germ cell tumor. |
Species: | Homo sapiens, human |
Tissue: | anterior mediastinal mixed germ cell tumor |
Disease: | pluripotent embryonal carcinoma; teratocarcinoma |
Gender: | male, adult, Japanese |
Morphology: | epithelial |
Growth Mode: | adherent |
Doubling Time: | N/A |
DNA Profile: | Amelogenin: X CSF1PO: 10,12 D13S317: 11 D16S539: 9,12 D5S818: 10,13 D7S820: 10 THO1: 7,9 TPOX: 8 vWA: 14,18 Cobioer’s Cell Line Authentication Service |
Culture Medium: | RPMI 1640+10% FBS We strongly suggest to purchase the complete medium from Cobioer. |
Cryopreservation medium: | 90%FBS+10%DMSO |
Antigen Expression: | N/A |
Receptor Expression: | N/A |
Oncogene: | N/A |
Genes Expressed: | N/A |
Cellular Products: | N/A |
Tumor Formation: | Yes, Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 107 cells. |
Comments: | This pluripotent stem cell line is capable of somatic and extraembryonic differentiation. The undifferentiated cells are equivalent to a stage intermediate between seminoma and embryonal carcinoma. They will differentiate in response to retinoic acid. NCCIT cells are negative for keratin. They are positive for vimentin and placental alkaline phosphatase. The line was contaminated with mycoplasma, but was cured by the depositor prior to deposit at the ATCC. For more information, please contact Cobioer (4008-750-250). |

扫一扫,关注我们公众号
Copyright ©2021 www.cobioer.com All Rights Reserved. 南京科佰生物科技有限公司版权所有 苏ICP备13038923号